Asthma therapeutics stands for the pharmaceutical drugs that are primarily adopted for the treatment of asthma. Asthma is a respiratory disease that usually gets triggered on exposure to several indoor and outdoor causative agents, such as dust, allergens, and pollutants. Asthma therapeutics generally include bronchodilators and anti-inflammatory drugs, such as long-acting beta-agonists (LABA), corticosteroids, methylxanthine, immunomodulators, and leukotriene modifiers. These drugs help in the expansion of air passage into the lungs, thereby enabling proper movement of air to improve breathing. Asthma therapeutics drugs are administered via inhalers or nebulizers and are adopted in quick-relief medications and long-term asthma control therapies.
Some of the key players being AstraZeneca (AZN), Abbott (ABT), Amgen Inc (AMGN), Biogen Inc (BIIB), Teva Pharmaceutical Industries Ltd (TEVA), GlaxoSmithKline plc. (GSK), Merck & Co. Inc. (MRK), Novartis AG (NVS), Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.), Boehringer Ingelheim GmbH, and F. Hoffmann-La Roche AG.
Request for a free sample report: https://www.imarcgroup.com/asthma-therapeutics-market/requestsample
The high prevalence of asthma due to the increasing air pollution levels is currently bolstering the demand for asthma therapeutics. Furthermore, the rising consumer awareness towards the wide availability of effective asthma therapeutics is also driving the market growth. The rapid development of combination therapies for the treatment of respiratory diseases, such as asthma, is further augmenting the demand for asthma therapeutics. Several pharma companies are constantly involved in the clinical trials of pipeline asthma drugs providing high efficacy and prolonged effect. Besides this, the increasing healthcare expenditures, rapid upgradation of healthcare infrastructures, and extensive R&D activities in the medical sector will continue to propel the market for asthma therapeutics.
Browse Full Report With TOC: https://www.imarcgroup.com/asthma-therapeutics-market
Key Market Segmentation
Breakup by Drug Class:
• Anti-Inflammatory Drugs
• Bronchodilators
• Combination Therapies
Breakup by Product Type:
• Inhalers
• Dry Powder Inhalers
• Metered Dose Inhalers
• Soft Mist Inhalers
• Nebulizers
• Pneumatic Nebulizers
• Ultrasonic Nebulizers
• Mesh Nebulizers
Breakup by Treatment Type:
• Quick-Relief Medications
• Long-Term Asthma Control Medications
Breakup by Route of Administration:
• Inhalation
• Oral
• Parenteral
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: [email protected]
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group